Percutaneous Infection Schistosoma mansoni Produce IL-7 In Vivo After Human Dermal Endothelial Cells and Keratinocytes

[1]  B. Autran,et al.  Primary Th1 cell immunization against HIVgp160 in SCID-hu mice coengrafted with peripheral blood lymphocytes and skin. , 1998, Journal of immunology.

[2]  Kenneth M. Yamada,et al.  Induction of T cell adhesion to extracellular matrix or endothelial cell ligands by soluble or matrix‐bound interleukin‐7 , 1997, European journal of immunology.

[3]  T. Kupper,et al.  IL-7 overexpression in transgenic mouse keratinocytes causes a lymphoproliferative skin disease dominated by intermediate TCR cells: evidence for a hierarchy in IL-7 responsiveness among cutaneous T cells. , 1997, Journal of immunology.

[4]  C. Carini,et al.  Modulation of TCR usage in HIV-1 infection is regulated by IL-7 and sCD23. , 1997, Allergologia et immunopathologia.

[5]  G. Soslau,et al.  Cytokine mRNA expression in human platelets and a megakaryocytic cell line and cytokine modulation of platelet function. , 1997, Cytokine.

[6]  C. Auriault,et al.  Interleukin‐7 in the skin of Schistosoma mansoni‐infected mice is associated with a decrease in interferon‐γ production and leads to an aggravation of the disease , 1997, Immunology.

[7]  A. Mantovani,et al.  Cytokine regulation of endothelial cell function: from molecular level to the bedside. , 1997, Immunology today.

[8]  F. Pimpinelli,et al.  Increased interleukin-7 concentrations in lesional skin and in the sera of patients with plaque-type psoriasis. , 1997, Clinical immunology and immunopathology.

[9]  Bos Jd.  The skin as an organ of immunity , 1997 .

[10]  H. Nakagawa,et al.  Changes in eosinophil and leukocyte infiltration and expression of IL-6 and IL-7 messenger RNA in mite allergen patch test reactions in atopic dermatitis. , 1996, The Journal of allergy and clinical immunology.

[11]  C. Carini,et al.  Interleukin-7 modulates intracytoplasmatic CD23 production and induces adhesion molecule expression and adhesiveness in activated CD4+CD23+ T cell subsets. , 1996, Clinical immunology and immunopathology.

[12]  M. Monsigny,et al.  Selective induction of peripheral and mucosal endothelial cell addressins with peripheral lymph nodes and Peyer's patch cell‐conditioned media , 1996, Journal of leukocyte biology.

[13]  B. Nickoloff,et al.  Dermal injection of immunocytes induces psoriasis. , 1996, The Journal of clinical investigation.

[14]  K. Ley,et al.  Molecular mechanisms of leukocyte recruitment in the inflammatory process. , 1996, Cardiovascular research.

[15]  J. Gerdes,et al.  Human follicular dendritic cells and vascular cells produce interleukin‐7: a potential role for interleukin‐7 in the germinal center reaction , 1996, European journal of immunology.

[16]  D. Rollinson,et al.  Royal Society of Tropical Medicine and Hygiene meeting at Manson House, London, 18 May 1995. The epidemiology of human schistosomiasis in the Senegal river basin. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[17]  D. Schadendorf,et al.  Interleukin‐7. Biology and implications for dermatology , 1996, Experimental dermatology.

[18]  E. E. Max,et al.  Infection of human endothelial cells with Epstein-Barr virus , 1995, The Journal of experimental medicine.

[19]  F. Lowy,et al.  Internalization of Staphylococcus aureus by endothelial cells induces cytokine gene expression , 1995, Infection and immunity.

[20]  S. Burdach,et al.  Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine , 1995, The Journal of experimental medicine.

[21]  B. Nickoloff,et al.  IL-7 in the cell-mediated immune response to a human pathogen. , 1995, Journal of immunology.

[22]  T. Edgington,et al.  Upregulation of human immunodeficiency virus-1 in chronically infected monocytic cell line by both contact with endothelial cells and cytokines. , 1994, Blood.

[23]  I. Shih,et al.  Development of pemphigus vulgaris-like lesions in severe combined immunodeficiency disease mice reconstituted with lymphocytes from patients. , 1993, The Journal of clinical investigation.

[24]  G. Schuler,et al.  Interleukin 7 is produced by murine and human keratinocytes , 1993, The Journal of experimental medicine.

[25]  D. Olive,et al.  Interleukin-7, a major T-lymphocyte cytokine. , 1993, European cytokine network.

[26]  M. Herlyn,et al.  Human/severe combined immunodeficient mouse chimeras. An experimental in vivo model system to study the regulation of human endothelial cell-leukocyte adhesion molecules. , 1993, The Journal of clinical investigation.

[27]  S. Osipova,et al.  [Immunity in schistosomiasis]. , 1993, Meditsinskaia parazitologiia i parazitarnye bolezni.

[28]  F. Auger,et al.  Comparative epidermal Langerhans cell migration studies in epidermal and epidermal/dermal equivalent grafts. , 1992, The Journal of investigative dermatology.

[29]  A. Kongs,et al.  Preliminary study of the prevalence of human schistosomiasis in Richard-Toll (the Senegal river basin). , 1992, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[30]  E. Bauer,et al.  Recessive dystrophic epidermolysis bullosa phenotype is preserved in xenografts using SCID mice: development of an experimental in vivo model. , 1992, The Journal of investigative dermatology.

[31]  L. Abel,et al.  Evidence for the segregation of a major gene in human susceptibility/resistance to infection by Schistosoma mansoni. , 1991, American journal of human genetics.

[32]  L. Picker,et al.  A unique phenotype of skin-associated lymphocytes in humans. Preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites. , 1990, The American journal of pathology.

[33]  R. Armitage,et al.  Human IL-7: a novel T cell growth factor. , 1989, Journal of immunology.

[34]  G. Krueger,et al.  Immunology/inflammation of the skin--a 50-year perspective. , 1989, The Journal of investigative dermatology.

[35]  H. A. Wilkins.  Reinfection after treatment of schistosome infections. , 1989, Parasitology today.

[36]  A. Prata,et al.  Human resistance to Schistosoma mansoni is associated with IgG reactivity to a 37-kDa larval surface antigen. , 1988, Journal of immunology.

[37]  C. March,et al.  B cell precursor growth-promoting activity. Purification and characterization of a growth factor active on lymphocyte precursors , 1988, The Journal of experimental medicine.

[38]  J. S. Cordingley,et al.  Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses. , 1985, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[39]  J. Streilein.  Skin-associated lymphoid tissues (SALT): origins and functions. , 1983, The Journal of investigative dermatology.

[40]  R. Wilson,et al.  An examination of the skin phase of schistosome migration using a hamster cheek pouch preparation , 1980, Parasitology.

[41]  R. Wilson,et al.  Schistosoma mansoni: a histological study of migration in the laboratory mouse , 1979, Parasitology.

[42]  R. Wilson,et al.  Migration of the schistosomula of Schistosoma mansoni from skin to lungs , 1978, Parasitology.

[43]  M. Taylor,et al.  Transformation of cercariae to schistosomula: A quantitative comparison of transformation techniques and of infectivity by different injection routes of the organisms produced , 1976, Journal of Helminthology.

[44]  N Katz,et al.  A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. , 1972, Revista do Instituto de Medicina Tropical de Sao Paulo.